Pfizer: Chantix Safe for Mentally Ill Smokers Who Want to Kick the Habit
June 9, 2008 by MedHeadlines
Filed under Drugs, FDA, Headlines, Smoking, Smoking Cessation
In an announcement made Thursday, Pfizer Inc, defended its drug, Chantix, prescribed to help smokers break the desire for nicotine. Chantix has been linked lately to thoughts of suicide and depression when taken by people who suffer from mental illness. Read more
New Safety Warnings for Chantix
February 3, 2008 by MedHeadlines
Filed under Drugs, Editor's Picks, FDA, Smoking Cessation
The U.S. Food and Drug Administration (FDA) has requested Pfizer to change its safety and precautions information regarding the use of Chantix (varenicline). The agency has evaluated reports on adverse effects of the drug since November 20, 2007. It now appears that there may be an association between Chantix and neuropsychiatric changes, such as agitation, depressed mood and suicidal behavior. Read more





